{"id":"https://openalex.org/W4376880378","doi":"https://doi.org/10.1136/bcr-2022-252739","title":"Dasatinib-associated follicular lymphoma in a patient with B-cell acute lymphoblastic leukaemia","display_name":"Dasatinib-associated follicular lymphoma in a patient with B-cell acute lymphoblastic leukaemia","publication_year":2023,"publication_date":"2023-05-01","ids":{"openalex":"https://openalex.org/W4376880378","doi":"https://doi.org/10.1136/bcr-2022-252739","pmid":"https://pubmed.ncbi.nlm.nih.gov/37197831","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10193045"},"language":"en","primary_location":{"id":"doi:10.1136/bcr-2022-252739","doi":"https://doi.org/10.1136/bcr-2022-252739","is_oa":false,"landing_page_url":"https://doi.org/10.1136/bcr-2022-252739","pdf_url":null,"source":{"id":"https://openalex.org/S141953298","display_name":"BMJ Case Reports","issn_l":"1757-790X","issn":["1757-790X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Case Reports","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10193045/pdf/bcr-2022-252739.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035472951","display_name":"Katherine Ismei Zhou","orcid":"https://orcid.org/0000-0001-6442-0475","observed_orcids":["https://orcid.org/0000-0001-6442-0475"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4210144876","display_name":"Duke University Health System","ror":"https://ror.org/03wfqwh68","country_code":"US","type":"education","lineage":["https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine Ismei Zhou","raw_affiliation_strings":["Division of Medical Oncology, Duke University Health System, Durham, North Carolina, USA"],"raw_orcid":"https://orcid.org/0000-0001-6442-0475","affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Duke University Health System, Durham, North Carolina, USA","institution_ids":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071583079","display_name":"Chenyu Lin","orcid":"https://orcid.org/0000-0002-4542-4232","observed_orcids":["https://orcid.org/0000-0002-4542-4232"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4210144876","display_name":"Duke University Health System","ror":"https://ror.org/03wfqwh68","country_code":"US","type":"education","lineage":["https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chenyu Lin","raw_affiliation_strings":["Division of Hematologic Malignancies & Cellular Therapy, Duke University Health System, Durham, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies & Cellular Therapy, Duke University Health System, Durham, North Carolina, USA","institution_ids":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065696758","display_name":"Jadee Neff","orcid":"https://orcid.org/0000-0002-4924-4247","observed_orcids":["https://orcid.org/0000-0002-4924-4247"]},"institutions":[{"id":"https://openalex.org/I4210144876","display_name":"Duke University Health System","ror":"https://ror.org/03wfqwh68","country_code":"US","type":"education","lineage":["https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jadee Lee Neff","raw_affiliation_strings":["Department of Pathology, Duke University Health System, Durham, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Duke University Health System, Durham, North Carolina, USA","institution_ids":["https://openalex.org/I4210144876"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101990764","display_name":"Ahmed Galal","orcid":"https://orcid.org/0000-0002-5962-5537","observed_orcids":["https://orcid.org/0000-0002-5962-5537"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4210144876","display_name":"Duke University Health System","ror":"https://ror.org/03wfqwh68","country_code":"US","type":"education","lineage":["https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ahmed Galal","raw_affiliation_strings":["Division of Hematologic Malignancies & Cellular Therapy, Duke University Health System, Durham, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies & Cellular Therapy, Duke University Health System, Durham, North Carolina, USA","institution_ids":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5065696758","https://openalex.org/A5101990764"],"corresponding_institution_ids":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"],"apc_list":null,"apc_paid":null,"fwci":0.189,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.4603205,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":94},"biblio":{"volume":"16","issue":"5","first_page":"e252739","last_page":"e252739"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.8583999872207642,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.8583999872207642,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.08560000360012054,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.00989999994635582,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.9760000109672546},{"id":"https://openalex.org/keywords/follicular-lymphoid-hyperplasia","display_name":"lymphoid follicular hyperplasia","score":0.8960000276565552},{"id":"https://openalex.org/keywords/philadelphia-chromosome-positive-acute-lymphoblastic-leukemia","display_name":"Philadelphia chromosome-positive acute lymphoblastic leukemia","score":0.9470000267028809},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitor-adverse-effects","display_name":"tyrosine kinase inhibitor adverse effects","score":0.8659999966621399},{"id":"https://openalex.org/keywords/drug-induced-lymphoproliferative-disorder","display_name":"drug-induced lymphoproliferative disorder","score":0.8700000047683716},{"id":"https://openalex.org/keywords/drug-withdrawal","display_name":"drug withdrawal","score":0.5929999947547913},{"id":"https://openalex.org/keywords/lymphadenopathy","display_name":"lymphadenopathy","score":0.675000011920929}],"concepts":[{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.9837050437927246},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7449624538421631},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.7330155372619629},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.5418539643287659},{"id":"https://openalex.org/C2908591792","wikidata":"https://www.wikidata.org/wiki/Q16999269","display_name":"Follicular hyperplasia","level":3,"score":0.5354305505752563},{"id":"https://openalex.org/C2993416501","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myeloid leukaemia","level":2,"score":0.5320003628730774},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5007555484771729},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4458848237991333},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.4453691244125366},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4272163212299347},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4101422131061554},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4060114026069641},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.395456999540329},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.3713643550872803},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.2338649034500122},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.13122868537902832},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07466483116149902}],"mesh":[{"descriptor_ui":"D000069439","descriptor_name":"Dasatinib","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010677","descriptor_name":"Philadelphia Chromosome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015452","descriptor_name":"Precursor B-Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1136/bcr-2022-252739","doi":"https://doi.org/10.1136/bcr-2022-252739","is_oa":false,"landing_page_url":"https://doi.org/10.1136/bcr-2022-252739","pdf_url":null,"source":{"id":"https://openalex.org/S141953298","display_name":"BMJ Case Reports","issn_l":"1757-790X","issn":["1757-790X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Case Reports","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10193045","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10193045","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10193045/pdf/bcr-2022-252739.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Case Rep","raw_type":"Text"},{"id":"pmid:37197831","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37197831","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ case reports","raw_type":"Case Reports"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:10193045","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10193045","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10193045/pdf/bcr-2022-252739.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Case Rep","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[{"id":"https://openalex.org/G4135008073","display_name":null,"funder_award_id":"HL007057-46","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G9000896211","display_name":"Hematology & Transfusion Medicine","funder_award_id":"T32HL007057","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"}],"funders":[{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4376880378.pdf","grobid_xml":"https://content.openalex.org/works/W4376880378.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W1592984486","https://openalex.org/W2010406094","https://openalex.org/W2067428197","https://openalex.org/W2078001907","https://openalex.org/W2082317665","https://openalex.org/W2095129762","https://openalex.org/W2261255074","https://openalex.org/W2398901848","https://openalex.org/W2609920254","https://openalex.org/W2615918143","https://openalex.org/W2725970815","https://openalex.org/W2746128771","https://openalex.org/W2908746540","https://openalex.org/W3096724129"],"related_works":["https://openalex.org/W2078001907","https://openalex.org/W4281398654","https://openalex.org/W2609920254","https://openalex.org/W2746128771","https://openalex.org/W2094984253","https://openalex.org/W7204805291","https://openalex.org/W3043583621","https://openalex.org/W4289994835","https://openalex.org/W7221289443","https://openalex.org/W1993808217"],"abstract_inverted_index":{"The":[0],"tyrosine":[1],"kinase":[2],"inhibitor":[3],"dasatinib":[4,24,57,88],"is":[5],"approved":[6],"for":[7,92],"the":[8],"treatment":[9,55],"of":[10,30,63,67,87,94],"chronic":[11],"myeloid":[12],"leukaemia":[13,20],"and":[14,58],"Philadelphia":[15],"chromosome-positive":[16],"(Ph+)":[17],"acute":[18],"lymphoblastic":[19],"(ALL).":[21],"Patients":[22],"on":[23],"can":[25,81],"rarely":[26],"develop":[27],"a":[28,43,77],"form":[29],"benign":[31],"reversible":[32],"reactive":[33],"lymphadenopathy":[34],"termed":[35],"follicular":[36,50],"lymphoid":[37],"hyperplasia":[38],"(FLH).":[39],"Here,":[40],"we":[41],"describe":[42],"patient":[44],"with":[45,56],"Ph+":[46],"ALL":[47],"who":[48,59],"developed":[49],"lymphoma":[51],"(FL)":[52],"after":[53,65],"prolonged":[54],"had":[60],"complete":[61],"remission":[62,93],"FL":[64],"discontinuation":[66],"dasatinib.":[68],"This":[69],"case":[70],"suggests":[71],"that":[72,80],"dasatinib-associated":[73,95],"FLH":[74],"could":[75],"be":[76,90],"premalignant":[78],"condition":[79],"transform":[82],"into":[83],"FL.":[84,96],"Moreover,":[85],"withdrawal":[86],"may":[89],"sufficient":[91]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-05-18T00:00:00"}